Hancock Jaffe Laboratories (HJLI) Stock Analysis

What Hancock Jaffe Laboratories does

Hancock Jaffe Laboratories, Inc. is a medical device company in its developmental stage, specializing in creating advanced tissue-based and biologic solutions. These innovations are engineered to either sustain or significantly enhance the lives of patients afflicted with cardiovascular, peripheral arterial, and venous diseases, as well as end-stage renal disease (ESRD). The firm, headquartered in Irvine, California, maintains a dedicated team of nine full-time employees. Among its key initiatives, the company is actively developing implantable bioprosthetic devices for cardiovascular applications. This includes the Bioprosthetic Heart Valve (BHV), a swine-derived heart valve designed to mimic the function of a native heart valve and provide superior performance compared to current prosthetic options. Furthermore, the company is developing a Venous Valve, another bioprosthetic device sourced from pig tissue. This valve is specifically designed for individuals suffering from chronic venous insufficiency (CVI) in the lower limbs, a condition frequently resulting from damage to leg vein valves after the formation of deep venous blood clots.

Key metrics

ETFs linked to HJLI

Broad-market and Healthcare sector ETFs an investor holding Hancock Jaffe Laboratories is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how HJLI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Hancock Jaffe Laboratories?

Hancock Jaffe Laboratories trades under the ticker HJLI on NASDAQ.

Which exchange is HJLI listed on?

HJLI is listed on NASDAQ.

What sector does Hancock Jaffe Laboratories operate in?

Hancock Jaffe Laboratories is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze HJLI in a portfolio?

PortView shows HJLI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.